News

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...
Most gene therapies being studied for eye diseases are in earlier phases of development, and a third of the gene therapies ...
The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or ...
A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...
Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...
The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
Creatine, a naturally occurring compound, enhances athletic performance and shows potential health benefits, but caution and ...
The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for ...
Summary:A new clinical trial found that cannabidiol (CBD) is safe and potentially helpful in reducing problematic behaviors ...
Zambon Pharma has received approval from Chinese regulatory authorities and launched Fluimucil (N-acetylcysteine).
Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...